Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Minerva Medica
|
January 16, 2019
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome
Antonello Nicolini, Matteo Ferrando, Paolo Solidoro, et al.
Frontiers in Medicine
|
September 16, 2017
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, et al.
Frontiers in Immunology
|
March 28, 2017
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
Gilda Varricchi, Gianenrico Senna, Stefania Loffredo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
February 8, 2018
Current insights in allergen immunotherapy
Giovanni Passalacqua, Diego Bagnasco, Matteo Ferrando, et al.
Current Pharmaceutical Biotechnology
|
April 18, 2017
New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
Matteo Ferrando, Diego Bagnasco, Giovanni Passa-Lacqua, et al.
Respiratory Care
|
March 27, 2020
The Relevance of Targeting Treatment to Small Airways in Asthma and COPD
Pierachille Santus, Dejan Radovanovic, Matteo Pecchiari, et al.
Current Opinion in Allergy and Clinical Immunology
|
December 1, 2017
Asthma: personalized and precision medicine
Giorgio W Canonica, Matteo Ferrando, Ilaria Baiardini, et al.
Allergy, Asthma & Immunology Research
|
November 10, 2016
Personalized Medicine in Allergy
Matteo Ferrando, Diego Bagnasco, Gilda Varricchi, et al.
Biomed Research International
|
December 7, 2018
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
Diego Bagnasco, Marco Caminati, Matteo Ferrando, et al.
Drug Safety
|
March 22, 2017
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations
Diego Bagnasco, Matteo Ferrando, Marco Caminati, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Minerva Medica
|
January 16, 2019
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome
Antonello Nicolini, Matteo Ferrando, Paolo Solidoro, et al.
Frontiers in Medicine
|
September 16, 2017
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, et al.
Frontiers in Immunology
|
March 28, 2017
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
Gilda Varricchi, Gianenrico Senna, Stefania Loffredo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
February 8, 2018
Current insights in allergen immunotherapy
Giovanni Passalacqua, Diego Bagnasco, Matteo Ferrando, et al.
Current Pharmaceutical Biotechnology
|
April 18, 2017
New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
Matteo Ferrando, Diego Bagnasco, Giovanni Passa-Lacqua, et al.
Respiratory Care
|
March 27, 2020
The Relevance of Targeting Treatment to Small Airways in Asthma and COPD
Pierachille Santus, Dejan Radovanovic, Matteo Pecchiari, et al.
Current Opinion in Allergy and Clinical Immunology
|
December 1, 2017
Asthma: personalized and precision medicine
Giorgio W Canonica, Matteo Ferrando, Ilaria Baiardini, et al.
Allergy, Asthma & Immunology Research
|
November 10, 2016
Personalized Medicine in Allergy
Matteo Ferrando, Diego Bagnasco, Gilda Varricchi, et al.
Biomed Research International
|
December 7, 2018
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
Diego Bagnasco, Marco Caminati, Matteo Ferrando, et al.
Drug Safety
|
March 22, 2017
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations
Diego Bagnasco, Matteo Ferrando, Marco Caminati, et al.
Page
of 3